Patent ID: 11874276
Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL
Field: Measurement (Instruments)
Classification: CPC C  G  A | IPC A  C  G

Claim 0:
1. A method for treating cancer in a subject comprising:
(i) obtaining a biological sample obtained from the subject having cancer, wherein the cancer is lung cancer;
(ii) determining the level of Stimulator of IFN Genes (STING); and
(iii) administering an effective amount of a therapy to the subject when the determined level of STING in the biological sample is below a reference value, thereby treating cancer in the subject,
wherein the therapy is a DNA methyltransferase inhibitor and/or an EZH2 inhibitor, wherein the DNA methyltransferase inhibitor and/or EZH2 inhibitor is GSK126, azacitidine, or decitabine.